UHPLC Analysis of Flakka and Related Compounds on Ascentis® Express RP-Amide in Reversed-Phase Mode
Materials
related product
Product No.
Description
Pricing
3,4-Methylenedioxypyrovalerone HCl (MDPV) solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®MDPBP hydrochloride solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®Naphyrone hydrochloride
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®α-Pyrrolidinovalerophenone hydrochloride solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®α-Pyrrolidinopropiophenone hydrochloride solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®CONDITIONS
column
Ascentis Express RP-Amide, 10 cm x 2.1 mm I.D., 2 μm (51576-U)
mobile phase
[A] 0.1% formic acid in water; [B] 0.1% formic acid in acetonitrile
gradient
5% to 95% A in 6 min
flow rate
0.4 mL/min
pressure
6400 psi
column temp.
35 °C
detector
UV, 265 nm
injection
1 μL
sample
50 μg/mL in 0.1% formic acid in water:0.1% formic acid in acetonitrile (90:10)
Description
Analysis Note
The rapid gradient separation of the street drug Flakka (α-PVP) and related compounds is shown here on an Ascentis Express RP-Amide column in reversed-phase mode. Highest grade UHPLC solvents were used to supply low background interference and low particulate contamination for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.
Legal Information
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany